Denial of prescription pain medication among people who use drugs in Vancouver, Canada
Piret EM, Milloy MJ, Voon P, Choi J, DeBeck K, Hayashi K, Kerr T., Harm Reduct J. 2024
Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada
Dubois C, Fernandes H, Lin M, Martins KJB, Dyck JRB, Klarenbach SW, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT., BMC Public Health., 2024
Navigating the nuances of the Canadian guideline’s stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders
Elefante RJO, Lu C, Bach PJ., CMAJ. 2024
Take-Home Naloxone Access and Use among Older Adults Living with Pain: A Scoping Review
Chan RRD, Yakiwchuk EM, Halpape K., Can J Hosp Pharm., 2024
Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review
Ng M, Carrieri PM, Awendila L, Socías ME, Knight R, Ti L., Can J Gastroenterol Hepatol. 2024
Perceptions of provider awareness of traditional and cultural treatments among Indigenous people who use unregulated drugs in Vancouver, Canada
Norton A, Homayra F, Defriend C, Barker B, Meilleur L, Hayashi K, Nosyk B., BMC Health Serv Res. 2024
“The machine doesn’t judge”: Counternarratives on surveillance among people accessing a safer opioid supply via biometric machines
Bardwell G, Ivsins A, Wallace JR, Mansoor M, Kerr T., Soc Sci Med. 2024
The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial
Bahji A, Bastien G, Bach P, Choi J, Le Foll B, Lim R, Jutras-Aswad D, Socias ME., Can J Psychiatry. 2024
Adverse Childhood Experiences and Problematic Cannabis Use: The Role of Emotion Dysregulation and Affective Impulsivity
Vieira JL, Snaychuk LA, Milicevic J, Hodgins DC, Shead NW, Keough MT, Kim HS., Cannabis, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study
Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A., Subst Abuse Treat Prev Policy. 2024
